HCV NS3 PROTEASE INHIBITORS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130178413A1
SERIAL NO

13825245

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to macrocyclic compounds of formula I that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MSD ITALIA SRLVIA VITORCHIANO 151 CAP ROMA 00189

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Crescenzi, Benedetta Paris, FR 9 131
Ferrara, Marco Milanese, IT 59 498
Gilbert, Kevin F Barto, US 11 199
Liverton, Nigel J Harleysville, US 51 720
McCauley, John A Maple Glen, US 67 584
Rudd, Michael T Collegeville, US 40 281
Summa, Vincenzo Roma, IT 41 480

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation